PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA
Clinical trials for PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA trials appear
Sign up with your email to follow new studies for PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cholesterol drug QLC7401 enters final testing phase
Disease control Not yet recruitingThis Phase 3 trial tests a new drug called QLC7401 in about 780 adults with high cholesterol that remains high despite standard therapy. Participants will receive either QLC7401 or a placebo, added to their current cholesterol medications. The main goal is to see if QLC7401 can s…
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New shot could tame high cholesterol without daily pills
Disease control Not yet recruitingThis Phase 3 trial tests a new injectable drug called QLC7401 in 510 adults with high cholesterol or mixed dyslipidemia who are not on other cholesterol treatments. Participants receive either the drug or a placebo as a shot under the skin. The main goal is to see how much it low…
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC